Related Experiment Video
Updated: Jun 1, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
MMPD-DTA: Integrating Multi-Modal Deep Learning with Pocket-Drug Graphs for Drug-Target Binding Affinity Prediction
Guishen Wang1, Hangchen Zhang1, Mengting Shao2
1College of Computer Science and Engineering, Changchun University of Technology, North Yuanda Street No. 3000, Jilin 130012, China.
Abstract:
Predicting drug-target binding affinity (DTA) is a crucial task in drug discovery research. Recent studies have demonstrated that pocket features and interactions between targets and drugs significantly improve the understanding of DTA. However, challenges remain, particularly in the detailed consideration of both global and local information and the further modeling of pocket features. In this paper, we propose a novel multimodal deep learning model named MMPD-DTA for predicting drug-target binding affinity to address these challenges. The MMPD-DTA model integrates graph and sequence modalities of targets, pockets, and drugs to capture both global and local target and drug information. The model introduces a novel pocket-drug graph (PD graph) that simultaneously models atomic interactions within the target, within the drug, and between the target and drug. We employ GraphSAGE for graph representation learning from the PD graph, complemented by sequence representation learning via transformers for the target sequence and graph representation learning via a graph isomorphism network for the drug molecular graph. These multimodal representations are then concatenated, and a multilayer perceptron generates the final binding affinity predictions. Experimental results on three real-world test sets demonstrate that the MMPD-DTA model outperforms baseline methods. Ablation studies further confirm the effectiveness of each module within the MMPD-DTA model. Our code is available at https://github.com/zhc-moushang/MMPD-DTA.
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Protein-protein Interfaces
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

